Bayer CropSci.

Who are the top shareholders of the Bayer CropSci.?

The top shareholders of Bayer CropScience include Bayer Vapi Private Limited with 17.89%, mutual funds holding 8.69%, foreign institutional investors at 3.49%, and individual investors collectively owning 8.88%. The largest public shareholder is Quant Mutual Fund, specifically the Quant Small Cap Fund, with a 2.32% stake.

The top shareholders of Bayer CropScience include Bayer Vapi Private Limited, which holds the highest stake at 17.89%. Additionally, the company has a diverse range of shareholders, with mutual funds holding 8.69% across 25 schemes and foreign institutional investors (FIIs) holding 3.49% through 143 different entities. The highest public shareholder is Quant Mutual Fund, specifically the Quant Small Cap Fund, with a holding of 2.32%. Individual investors collectively own 8.88% of the company.

What does Bayer CropSci. do?

Bayer CropScience Ltd, established in 1958, is a leading Indian company in the agriculture sector, focusing on pesticides and agrochemicals, with a market cap of Rs 24,831 Cr and a net profit of 143 Cr as of March 2025. Key metrics include a P/E ratio of 44.00 and a dividend yield of 2.25%.

Overview:<BR>Bayer CropScience Ltd is a key player in the Indian agriculture industry, specializing in pesticides and agrochemicals, and is categorized as a Large Cap company.<BR><BR>History:<BR>Bayer CropScience Ltd was incorporated in 1958 and was formerly known as Bayer (India) Limited until its name change on February 24, 2004. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,046 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 143 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 24,831 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 44.00<BR>- Industry P/E: 38<BR>- Dividend Yield: 2.25%<BR>- Debt Equity: -0.43<BR>- Return on Equity: 19.93%<BR>- Price to Book: 8.77<BR><BR>Contact Details:<BR>- Address: Bayer House Central Avenue, Hiranandani Estate Thane (West) Maharashtra : 400607<BR>- Tel: 91-022-25311234<BR>- Email: ir_bcsl@bayer.com<BR>- Website: http://www.bayer.in

When is the next results date for Bayer CropSci.?

No Upcoming Board Meetings

Has Bayer CropSci. declared dividend?

Yes, Bayer CropScience Ltd has declared a 900% dividend, amounting to ₹90 per share, with an ex-date of November 28, 2024. While recent performance shows a -8.52% return over the last 6 months, longer-term returns have been positive, particularly with a total return of 31.9% over the past 2 years.

Bayer CropScience Ltd has declared a 900% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 900%<BR>- Amount per share: 90 per share<BR>- Ex-date: 28 Nov 2024<BR><BR>Dividend Yield: 2.25%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -8.52%, the dividend return was 0%, resulting in a total return of -8.52%.<BR><BR>Over the past year, the price return was 0.48%, the dividend return was 2.06%, leading to a total return of 2.54%.<BR><BR>In the 2-year period, the price return was 25.8%, the dividend return was 6.10%, which culminated in a total return of 31.9%.<BR><BR>For the 3-year period, the price return was 4.25%, the dividend return was 7.91%, resulting in a total return of 12.16%.<BR><BR>In the last 4 years, the price return was 4.34%, the dividend return was 9.47%, leading to a total return of 13.81%.<BR><BR>Over the past 5 years, the price return was 2.76%, the dividend return was 9.05%, culminating in a total return of 11.81%.<BR><BR>Overall, Bayer CropScience Ltd has declared a significant dividend, and while the recent 6-month performance shows a decline, the longer-term returns indicate a positive trend, particularly in the 2-year and 3-year periods.

Who are the peers of the Bayer CropSci.?

Bayer CropSci.'s peers include P I Industries, UPL, Sumitomo Chemical, Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chemical, Bharat Rasayan, and NACL Industries. Management risk varies from excellent to average among peers, with Sharda Cropchem showing the highest 1-year return at 102.43%, while Bayer CropSci. has a 1-year return of 10.06%.

Peers: The peers of Bayer CropSci. are P I Industries, UPL, Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and P I Industries, while Good management risk is found at Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, and Average management risk is present at UPL, Rallis India, Bhagiradha Chem., and NACL Industries. Growth is rated as Excellent for P I Industries, while Below Average growth is seen at Bayer CropSci., UPL, Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries. Capital Structure is rated Excellent for Bayer CropSci., P I Industries, Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, and Bharat Rasayan, while Good capital structure is found at Bhagiradha Chem., and Average capital structure is present at UPL, Rallis India, and NACL Industries.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sharda Cropchem at 102.43%, while the lowest is Bharat Rasayan at -12.17%. Bayer CropSci.'s 1-year return is 10.06%, which is higher than Bharat Rasayan's but lower than Sharda Cropchem's. Additionally, the six-month return is negative for Bayer CropSci., UPL, Sumitomo Chemi., and Bharat Rasayan.

Who are in the management team of Bayer CropSci.?

As of March 2022, Bayer CropSci's management team includes Pankaj Patel (Chairman), Duraiswami Narain (CEO), and Simon Britsch (CFO), along with several independent and non-executive directors. The team is diverse, covering various roles in leadership and compliance.

As of March 2022, the management team of Bayer CropSci includes the following members:<BR><BR>1. Pankaj Patel - Chairman & Independent Director<BR>2. Duraiswami Narain - Vice Chairman, Managing Director & CEO<BR>3. Ketaki Bhagwati - Non-Executive & Independent Director<BR>4. Thomas Hoffmann - Non-Executive & Non-Independent Director<BR>5. Sekhar Natarajan - Non-Executive & Independent Director<BR>6. Nikunjkumar Savaliya - Company Secretary & Compliance Officer<BR>7. Harsh Kumar Bhanwala - Non-Executive & Independent Director<BR>8. Simon Wiebusch - Whole-time Director<BR>9. Simon Britsch - Executive Director & CFO<BR>10. Brian Naber - Non-Executive & Non-Independent Director<BR><BR>This diverse team encompasses various roles, including independent directors, executive positions, and compliance oversight.

How big is Bayer CropSci.?

As of 24th July, Bayer CropScience Ltd has a market capitalization of 28,727.00 Cr, with recent net sales of 5,472.60 Cr and a net profit of 568.00 Cr.

As of 24th July, Bayer CropScience Ltd has a market capitalization of 28,727.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, Bayer CropScience reported Net Sales of 5,472.60 Cr and a Net Profit of 568.00 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 2,849.40 Cr and Total Assets of 4,597.10 Cr.

Is Bayer CropSci. technically bullish or bearish?

As of October 16, 2025, Bayer CropSci. exhibits a bearish trend with significant weakness, indicated by bearish MACD, moving averages, and KST across multiple time frames, despite a mildly bullish signal from Dow Theory.

As of 16 October 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Bayer CropSci. is bearish with a strong indication of weakness. The weekly MACD is bearish, and the daily moving averages confirm this bearish outlook. The KST is also bearish on both weekly and monthly time frames. While the Bollinger Bands are mildly bearish, the Dow Theory shows a mildly bullish signal on the weekly chart, which is not strong enough to counter the overall bearish sentiment. The stock has underperformed significantly over the past year, with a return of -24.30% compared to the Sensex's 2.41%. Overall, the indicators suggest a bearish trend with considerable weakness.

Is Bayer CropSci. overvalued or undervalued?

As of October 17, 2025, Bayer CropScience is considered overvalued with a PE ratio of 38.24 and a year-to-date return of -9.24%, indicating it may not be a favorable investment compared to its peers and the Sensex.

As of 17 October 2025, Bayer CropScience's valuation grade has moved from very expensive to expensive, indicating a slight improvement but still reflecting a high valuation. The company is currently considered overvalued. Key ratios include a PE ratio of 38.24, an EV to EBITDA of 30.04, and a Price to Book Value of 7.95, all of which suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Bayer CropScience's PE ratio is higher than UPL's 37.91 and BASF India's 47.93, which are both classified as attractive. The PEG ratio stands at 0.00, indicating no growth expectations factored into the price, which is concerning. Recent stock performance shows that Bayer has underperformed against the Sensex, with a year-to-date return of -9.24% compared to the Sensex's 7.44%, reinforcing the notion that the stock may not be a favorable investment at its current valuation.

How has been the historical performance of Bayer CropSci.?

Bayer CropSci. has shown increasing net sales, reaching 5,473.40 Cr in March 2025, but experienced declines in operating profit, profit before tax, and profit after tax. Despite asset growth to 5,236.20 Cr, cash flow from operating activities significantly decreased, resulting in a net cash outflow of 271.00 Cr.

Answer:<BR>The historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. However, operating profit (PBDIT) has seen a decline from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax also decreased to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period. The company's total assets increased to 5,236.20 Cr in March 2025, compared to 4,597.10 Cr in March 2024, indicating growth in the asset base. Total liabilities also rose to 5,236.20 Cr from 4,597.10 Cr, reflecting an increase in financial obligations. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash outflow of 271.00 Cr in March 2025.<BR><BR>Breakdown:<BR>Bayer CropSci. has demonstrated a consistent increase in net sales, achieving 5,473.40 Cr in March 2025, a rise from previous years, although operating profit has declined from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax and profit after tax also saw reductions, with figures of 707.40 Cr and 568.00 Cr respectively in March 2025. The total assets of the company increased to 5,236.20 Cr, indicating a growing asset base, while total liabilities rose correspondingly to the same figure, suggesting a balance between asset growth and financial obligations. The cash flow from operating activities has notably decreased to 262.00 Cr, leading to a net cash outflow of 271.00 Cr, which highlights challenges in cash generation despite the growth in sales.

Are Bayer CropScience Ltd latest results good or bad?

Bayer CropScience Ltd's latest Q3 FY26 results are considered weak, with a 45.21% decline in net profit and an 18.87% drop in revenue quarter-on-quarter. Despite these challenges, the company maintains a strong balance sheet with no long-term debt.

Bayer CropScience Ltd's latest results for Q3 FY26 indicate a challenging quarter. The company reported a net profit of ₹152.70 crores, which represents a significant decline of 45.21% quarter-on-quarter. Revenue also fell sharply to ₹1,553.40 crores, down 18.87% from the previous quarter and 10.60% year-on-year. Additionally, both operating and PAT margins contracted, with operating margins dropping to 13.22% from 18.20% in the previous quarter.<BR><BR>These results reflect the seasonal nature of the agrochemicals business, as Q3 typically sees lower demand compared to the peak kharif season. Despite these challenges, Bayer CropScience maintains a strong balance sheet with zero long-term debt and a stable promoter holding of 71.43%, which suggests some confidence in its long-term prospects.<BR><BR>Overall, while the company has solid fundamentals and a robust financial position, the latest quarterly performance is considered weak due to the significant declines in both revenue and profit margins.

Should I buy, sell or hold Bayer CropScience Ltd?

Why is Bayer CropScience Ltd falling/rising?

As of 17-Mar, Bayer CropScience Ltd's stock price is declining, currently at Rs 4,461.10, reflecting a bearish trend with significant underperformance and reduced investor participation. The stock has decreased by 3.11% over the past week and is trading below all major moving averages, indicating a lack of upward momentum.

As of 17-Mar, Bayer CropScience Ltd's stock price is falling, currently at Rs 4,461.10, reflecting a decrease of Rs 59.6 or 1.32%. The stock has underperformed its sector by 1.64% today and has experienced a trend reversal after two consecutive days of gains. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>In terms of recent performance, the stock has declined by 3.11% over the past week and 6.21% over the past month, while year-to-date it has decreased by 2.18%. Notably, the stock is also 4.13% away from its 52-week low, suggesting a lack of upward momentum. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 29.6% compared to the 5-day average. This decline in trading activity may contribute to the downward pressure on the stock price. <BR><BR>Overall, the combination of negative performance metrics, underperformance relative to the sector, and reduced investor participation are key factors contributing to the current decline in Bayer CropScience Ltd's stock price.

Why is Bayer CropScience Ltd falling/rising?

As of 18-Mar, Bayer CropScience Ltd's stock price is slightly rising at 4,493.30, but it has underperformed over the past month and year, trading below its moving averages and close to its 52-week low. Despite a minor uptick, the overall performance remains weak compared to its sector, although there is increased investor interest indicated by a rise in delivery volume.

As of 18-Mar, Bayer CropScience Ltd's stock price is rising slightly, with a current price of 4,493.30, reflecting a change of 11.05 (0.25%) upwards. Despite this minor increase, the stock has shown a negative performance over various periods, including a decline of 7.04% over the past month and 7.55% over the past year. The stock is currently trading lower than its moving averages across multiple time frames, indicating a general downward trend.<BR><BR>Additionally, the stock is close to its 52-week low, being only 4.82% away from Rs 4276.85. It has underperformed its sector by 1.38% today, which suggests that while there is a slight uptick in price, the overall performance remains weak compared to its peers. However, there is a positive aspect in the rising investor participation, as evidenced by a 14.58% increase in delivery volume compared to the 5-day average, indicating some level of interest from investors.<BR><BR>Overall, while the stock has experienced a small rise today, the broader context shows significant challenges, including underperformance relative to benchmarks and moving averages, which may contribute to a cautious outlook among investors.

Why is Bayer CropScience Ltd falling/rising?

As of 19-Mar, Bayer CropScience Ltd's stock price is at 4,482.25, reflecting a decline of 1.95 (-0.04%). The stock has underperformed the market, with a year-to-date drop of 1.72%, and is trading below its moving averages amid weak sector performance and decreased investor participation.

As of 19-Mar, Bayer CropScience Ltd's stock price is falling, currently at 4,482.25, which reflects a decrease of 1.95 (-0.04%). The stock has underperformed relative to the broader market, with a 1-week decline of 0.52% compared to a 2.40% drop in the Sensex. Over the past month, the stock has decreased by 5.98%, while the Sensex has fallen by 10.05%. Year-to-date, Bayer CropScience has seen a decline of 1.72%, which is significantly better than the Sensex's 12.92% drop.<BR><BR>Despite some positive financial indicators, such as a high return on equity (ROE) of 21.04% and a low debt-to-equity ratio, the stock is trading below all its moving averages, indicating a bearish trend. Additionally, the sector performance has been weak, with the Pesticides & Agrochemicals sector declining by 2.22%. Investor participation has also decreased, as evidenced by a 32.92% drop in delivery volume compared to the 5-day average. Furthermore, the stock is close to its 52-week low, being only 4.58% away from it. These factors collectively contribute to the downward pressure on Bayer CropScience Ltd's stock price.

Why is Bayer CropScience Ltd falling/rising?

As of 20-Mar, Bayer CropScience Ltd's stock price is rising to 4,699.80, up 5.26%, driven by strong financial performance, high management efficiency, and relative sector outperformance. Despite a slight decline in delivery volume, overall liquidity remains sufficient, contributing to the stock's positive momentum.

As of 20-Mar, Bayer CropScience Ltd's stock price is rising, currently at 4,699.80, reflecting an increase of 234.95 or 5.26%. This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 3.66% today, indicating strong relative performance. Additionally, the stock reached an intraday high of Rs 4785.95, which is a 7.19% increase, showcasing positive momentum.<BR><BR>Moreover, the company has demonstrated high management efficiency, evidenced by a return on equity (ROE) of 21.04% and a low debt-to-equity ratio, which suggests a solid financial foundation. Recent financial results have also been impressive, with profit before tax (PBT) growing significantly by 6835.71% and profit after tax (PAT) increasing by 179.8% for the quarter ending December 25.<BR><BR>Despite a slight decline in delivery volume, which fell by 1.54% against the 5-day average, the overall liquidity remains sufficient for trading. The stock's performance over the past week shows a gain of 4.17%, contrasting with a slight decline in the benchmark Sensex, which fell by 0.04%. This combination of strong financial results, effective management, and relative sector performance contributes to the current rise in Bayer CropScience Ltd's stock price.

Which are the latest news on Bayer CropSci.?